PharmaSource Podcast: The Promise of Cell & Gene Therapy to Reshape Healthcare, with Devyn Smith, CEO Arbor Biotech
Description
Gene editing and cell therapy, they’re going to be entrenched modalities, much like small molecules and antibodies are today, that will fundamentally reshape healthcare.” says Devyn Smith.
Devyn Smith, CEO of Arbor Biotechnologies and Chairman of the Alliance for Regenerative Medicine, brings a wealth of experience to the cell and gene therapy ecosystem. With a PhD in developmental biology and eight years in strategy consulting, Devyn’s journey led him to Pfizer, where he served as COO of their cell therapy group in Cambridge, UK, before a series of board roles at various biotechs.
In the latest PharmaSource podcast episode, he shares insights on the promise of cell and gene therapy to transform lives and the operational challenges the industry must overcome to realise this potential.
Episode: https://podcasters.spotify.com/pod/show/life-science-networks/episodes/The-Promise-of-Cell--Gene-Therapy-to-Reshape-Healthcare--with-Devyn-Smith--CEO-Arbor-Biotech-e2sih4s
Podcast: https://pharmasource.global/homepage/
United States
